Body composition and mortality in chronic obstructive pulmonary disease
Open accessThe DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index; 1 of the 47 sources its claims cite were checked for support.
Overview
CoChat Summary
TL;DR
In 412 patients with moderate-to-severe COPD, fat-free mass index independently predicted all-cause mortality, whereas fat mass index did not. Low fat-free mass categories (cachexia and muscle atrophy) had worse survival than no impairment, supporting body-composition assessment as a systemic marker in COPD staging.
Key findings
- During a maximum follow-up of 5 y (mean 48 ± 20 mo), 46% of patients (n = 189) died.
- After adjustment for age, sex, FEV₁, IVC, PaCO₂, and PaO₂, fat-free mass index was an independent predictor of mortality (RR: 0.90; 95% CI: 0.84, 0.96; P = 0.003), but fat mass index was not (RR: 1.02; 95% CI: 0.95, 1.09; P = 0.680).
- Median survival was significantly worse in cachexia (26 mo; 95% CI: 21, 31 mo) and muscle atrophy (24 mo; 95% CI: 15, 33 mo) than in semistarvation (36 mo; 95% CI: 28, 44 mo) or no impairment (47 mo; 95% CI: 37, 57 mo) (P < 0.001).
- Cachexia was significantly more prevalent in GOLD stage IV than in GOLD stages II and III (P = 0.001); by SMI criteria, 51% of the total population was at moderate and 31% at high risk of physical disability.
Methods
- Cohort study of 412 clinically stable COPD patients (GOLD stages II–IV; FEV₁ 36 ± 14% of predicted, range 19–70%) screened for admission to a clinical pulmonary rehabilitation program between 1 January 1988 and 30 December 1991; mortality was assessed on 31 January 1993, with follow-up of 2–5 y or until death.
- Body composition was assessed by single-frequency bioelectrical impedance (50 Hz); fat-free mass was calculated with disease-specific equations, fat mass as body weight minus fat-free mass, and FFMI, FMI, and SMI were calculated and compared with reference values. Patients were stratified into cachexia, semistarvation, muscle atrophy, or no impairment by BMI and FFMI cutoffs.
- Main analysis used Kaplan-Meier survival curves, log-rank tests, and Cox proportional hazards models, unadjusted and adjusted for age, sex, disease severity (FEV₁, IVC, PaO₂, PaCO₂), and GOLD classification; P < 0.05 was considered significant.
Limitations
- Stated in the paper: the study population was skewed toward more males and more severe GOLD stages III and IV, and the semistarvation and muscle atrophy categories were relatively small.
- Stated in the paper: smoking status was not objectively verified (e.g., by cotinine measurements), and because smoking was not associated with mortality in these subjects, the reported models excluded smoking.
- Evident from the text: body composition was measured only at baseline, so the sequence of body-composition changes could not be established; emphysema severity was not adjusted for despite being discussed as potentially relevant; and the cohort was selected from rehabilitation screening in the southern Netherlands, which may limit generalizability.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
0 Valid · 0 Not valid · 27 Not checked · 36 Own results and interpretations
None of the sources cited for this claim have been checked yet.
In the paper
“These studies all indicate that BIA may be a useful clinical screening instrument for characterization of the tissue-depletion pattern in chronic lung disease.”
§ Body composition and mortality in chronic obstructive pulmonary disease 1,2 > DISCUSSION
What the sources say
- Not checked yetcites [12] Janssen I, Heymsfield SB, Baumgartner RN, Ross R. Estimation of skeletal muscle mass by bioelectrical impedance analysis. J Appl Physiol 2000;89:465-71. source
Checked before — its earlier verdict is held back until a new check runs.
- Not checked yetcites [19] Janssen I, Baumgartner RN, Ross R, Rosenberg IH, Roubenoff R. Skel- etal muscle cutpoints associated with elevated physical disability risk in older men and women. Am J Epidemiol 2004;159:413-21. source
Checked before — its earlier verdict is held back until a new check runs.
- Could not verifycites [20] Gosker HR, Engelen MP, van Mameren H, et al. Muscle fiber type IIX atrophy is involved in the loss of fat-free mass in chronic obstructive pulmonary disease. Am J Clin Nutr 2002;76:113-9. sourceExperimental — accuracy not yet measured
Our copy of Gosker et al. (2002) only uses BIA as one of two ways to determine fat-free mass (Methods, 'Assessment of body composition': single-frequency 50 kHz BIA with the disease-specific equation of Schols et al, ref 13) and reports that FFM_BIA correlated with total mean fiber cross-sectional area in the COPD patients (Results/'3-5' passage and Figure 3, r = 0.87, P < 0.001). No passage in our copy evaluates or states that BIA is a useful clinical screening instrument, nor does it use the notion of a 'tissue-depletion pattern' or generalize beyond its 15 stable COPD patients versus 15 controls (Study population). Searched: 'bioelectrical impedance analysis useful clinical screening instrument tissue depletion chronic lung disease', 'FFM BIA validity comparison DXA', 'screening instrument tissue depletion pattern chronic lung disease', 'discussion BIA fat-free mass muscle mass loss wasting clinical implications' — none returned a statement on BIA's screening utility. The validating comparison of BIA with deuterium dilution is credited elsewhere in the reference list (Schols et al. 1991, ref 13), but our copy does not attribute the screening-instrument conclusion to it, so this is not misattribution on our evidence. (LLM, conf=0.62)
hedgedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption not shown here.
- Not checked yet
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Cachexia was significantly (P ҃ 0.001) more prevalent in GOLD stage IV than in GOLD stages II and III.”
- Also stated in: § Abstract · plain
“Semistarvation and muscle atrophy were equally distributed among disease stages, but the highest prevalence of cachexia was seen in GOLD stage IV.”
§ Body composition and mortality in chronic obstructive pulmonary disease 1,2 > 6 x Ȁ SD (all such values).
plainstates an associationn = 412- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § Abstract · plain
None of the sources cited for this claim have been checked yet.
In the paper
“In line with that study, male patients in the current study were at higher risk of physical disability than were female patients.”
§ Body composition and mortality in chronic obstructive pulmonary disease 1,2 > RESULTS
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Univariate analysis showed that low BMI, FFMI, and FMI were significantly associated with increased mortality risk (Table 3).”
§ Body composition and mortality in chronic obstructive pulmonary disease 1,2 > 6 x Ȁ SD (all such values).
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Forty-six percent of the patients (n ҃ 189) died during a maximum follow-up of 5 y.”
- Also stated in: § 6 x Ȁ SD (all such values). · plain
“The mean duration of follow-up was 48 Ȁ 20 mo, during which time 46% of the patients died.”
§ Body composition and mortality in chronic obstructive pulmonary disease 1,2 > Abstract
plainn = 189- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § 6 x Ȁ SD (all such values). · plain
32 more claims
Create a free account to see all 63 claims and to verify the 42 references still open.
- It may state two separate claims as one. 16
- Probably not a substantial claim. 13
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Body composition and mortality in chronic obstructive pulmonary disease 1,2 > 6 x Ȁ SD (all such values).
“1.23”
§ Body composition and mortality in chronic obstructive pulmonary disease 1,2 > 6 x Ȁ SD (all such values).
“1.68, 2.24; NS”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Body composition and mortality in chronic obstructive pulmonary disease 1,2 > RESULTS
“Mean FFMI in categories 2 and 4 was within median range (50th percentile) except for male patients in category 2, whose values were below the 10th percentile.”
§ Body composition and mortality in chronic obstructive pulmonary disease 1,2 > DISCUSSION
“4: No impairment (n ҃ 55) | 59 | 17.6 Ȁ 2.2 | 90th”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Body composition and mortality in chronic obstructive pulmonary disease 1,2 > DISCUSSION
“physical disability risk was clearly lower in categories 3 and 4”
§ Body composition and mortality in chronic obstructive pulmonary disease 1,2 > RESULTS
“significantly (P 0.001) more patients were at moderate to high risk of disability in the cachexia and muscle atrophy categories (ie, 1 and 3) than in semistarvation and noimpairment categories (ie, 2 and 4)”
Citations
Cites
Celli, B. R., Cote, C. G., Marin, J. M., Casanova, C., Montes de Oca, M., Mendez, R. A., Pinto Plata, V., & Cabral, H. J. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa021322 · Cited by 4,015 · cited 1×
“On the basis of numerous reports showing an association between BMI and mortality risk in COPD, Celli at al (26) recently proposed that clinical staging for COPD should be based not only on spirometry and resting arterial blood gases, eg, the recent GOLD criteria, but also on BMI, exercise capacity, and dyspnea score.”
BackgroundAssessment of fat-free mass using bioelectrical impedance measurements of the human body
Lukaski, H., Johnson, P., Bolonchuk, W., & Lykken, G. (1985) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/41.4.810 · Cited by 1,896 · cited 1×
“Bioelectrical impedance analysis (BIA) is an easy, safe, noninvasive, and convenient method of measuring the lean and fat body compartments (11).”
MethodEstimation of skeletal muscle mass by bioelectrical impedance analysis
Janssen, I., Heymsfield, S. B., Baumgartner, R. N., & Ross, R. (2000) · Journal of Applied Physiology · doi:10.1152/jappl.2000.89.2.465 · Cited by 1,482
Skeletal Muscle Cutpoints Associated with Elevated Physical Disability Risk in Older Men and Women
Janssen, I. (2004) · American Journal of Epidemiology · doi:10.1093/aje/kwh058 · Cited by 1,190
Weight Loss Is a Reversible Factor in the Prognosis of Chronic Obstructive Pulmonary Disease
SCHOLS, A. M. W. J., SLANGEN, J., VOLOVICS, L., & WOUTERS, E. F. M. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.157.6.9705017 · Cited by 1,085
Self-citationPrognostic Value of Nutritional Status in Chronic Obstructive Pulmonary Disease
LANDBO, C., PRESCOTT, E., LANGE, P., VESTBO, J., & ALMDAL, T. P. (1999) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.160.6.9902115 · Cited by 1,033
Marquis, K., Debigaré, R., Lacasse, Y., LeBlanc, P., Jobin, J., Carrier, G., & Maltais, F. (2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.2107031 · Cited by 844
Schols, A. M. W. J., Soeters, P. B., Dingemans, A. M. C., Mostert, R., Frantzen, P. J., & Wouters, E. F. M. (1993) · American Review of Respiratory Disease · doi:10.1164/ajrccm/147.5.1151 · Cited by 725
Self-citationFat-free mass index and fat mass index percentiles in Caucasians aged 18–98 y
Schutz, Y., Kyle, U., & Pichard, C. (2002) · International Journal of Obesity · doi:10.1038/sj.ijo.0802037 · Cited by 670
Schols, A. M., Soeters, P. B., Mostert, R., Pluymers, R. J., & Wouters, E. F. (1995) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.152.4.7551381 · Cited by 463
Self-citation
Cited by
Items 201–300 of 898
Camiciottoli, G., Bigazzi, F., Magni, C., Bonti, V., Diciotti, S., Bartolucci, M., Mascalchi, M., & Pistolesi, M. (2016) · International Journal of COPD · doi:10.2147/copd.s111724 · Cited by 64
Chronic obstructive pulmonary disease and the metabolic syndrome: Consequences of a dual threat
Thomas, N., Naik, D., Joshi, A., & Paul, T. V. (2014) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/2230-8210.139212 · Cited by 64
Acute environmental hypoxia induces LC3 lipidation in a genotype‐dependent manner
Masschelein, E., Van Thienen, R., D'Hulst, G., Hespel, P., Thomis, M., & Deldicque, L. (2014) · The FASEB Journal · doi:10.1096/fj.13-239863 · Cited by 53
Frailty assessment in older adults with chronic obstructive respiratory diseases
Guan, C., & Niu, H. (2018) · Clinical Interventions in Aging · doi:10.2147/cia.s173239 · Cited by 64
Effect of acute environmental hypoxia on protein metabolism in human skeletal muscle
D’Hulst, G., Jamart, C., Thienen, R. V., Hespel, P., Francaux, M., & Deldicque, L. (2013) · Acta Physiologica · doi:10.1111/apha.12086 · Cited by 64
Liu, P., Wang, X., Fan, J., Xiao, W., & Wang, Y. (2016) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph13030341 · Cited by 62
Perrot, L., Greil, A., Boirie, Y., Farigon, N., Mulliez, A., Costes, F., & Caillaud, D. M. (2020) · European Journal of Clinical Nutrition · doi:10.1038/s41430-020-0623-6 · Cited by 62
New Modalities of Pulmonary Rehabilitation in Patients with Chronic Obstructive Pulmonary Disease
Spruit, M. A., & Wouters, E. F. �. (2007) · Sports Medicine · doi:10.2165/00007256-200737060-00004 · Cited by 62
Self-citationTreatment of severe stable COPD: the multidimensional approach of treatable traits
van Dijk, M., Gan, C. T., Koster, T. D., Wijkstra, P. J., Slebos, D., Kerstjens, H. A. M., van der Vaart, H., & Duiverman, M. L. (2020) · ERJ Open Research · doi:10.1183/23120541.00322-2019 · Cited by 61
Passey, S. L., Hansen, M. J., Bozinovski, S., McDonald, C. F., Holland, A. E., & Vlahos, R. (2016) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2016.06.013 · Cited by 61
Association between hemoglobin and prognosis in patients admitted to hospital for COPD
Toft‐Petersen, A. P., Torp-Pedersen, C. T., Weinreich, U. M., & Rasmussen, B. S. (2016) · International Journal of COPD · doi:10.2147/copd.s116269 · Cited by 61
Diago, C. A. A., García‐Unzueta, M. T., Lavín, B. A., Guerra-Ruiz, A. R., Calvo, J. A., Ramos, L., & Muñoz, P. (2018) · Respiration · doi:10.1159/000494296 · Cited by 61
Update in Chronic Obstructive Pulmonary Disease 2005
Fabbri, L. M., Luppi, F., Beghé, B., & Rabe, K. F. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.2603005 · Cited by 61
Global assessment of the COPD patient: Time to look beyond FEV1?
Papaioannou, A. Ι., Loukides, S., Gourgoulianis, K. I., & Κostikas, Κ. (2009) · Respiratory Medicine · doi:10.1016/j.rmed.2009.01.001 · Cited by 60
The possible role of myostatin in skeletal muscle atrophy and cachexia
Jespersen, J., Kjær, M., & Schjerling, P. (2005) · Scandinavian Journal of Medicine and Science in Sports · doi:10.1111/j.1600-0838.2005.00498.x · Cited by 61
Contribution of the Mitochondria to Locomotor Muscle Dysfunction in Patients with COPD
Taivassalo, T., & Hussain, S. N. A. (2016) · Chest · doi:10.1016/j.chest.2015.11.021 · Cited by 59
Mou, K., Chan, S. M. H., & Vlahos, R. (2024) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2024.108635 · Cited by 59
Biomarkers, the control panel and personalized COPD medicine
Agustí, A. G. N., Gea, J., & Faner, R. (2015) · Respirology · doi:10.1111/resp.12585 · Cited by 59
Ferrari, R., Caram, L., Faganello, M., Sanchez, F., Tanni, S., & Godoy, I. (2015) · International Journal of Chronic Obstructive Pulmonary Disease · doi:10.2147/copd.s85954 · Cited by 52
Kim, Y. S., Kim, E. Y., Kang, S. M., Ahn, H. K., & Kim, H. S. (2015) · Clinical Physiology and Functional Imaging · doi:10.1111/cpf.12333 · Cited by 59
The translation of age-related body composition findings from rodents to humans
Pappas, L. E., & Nagy, T. R. (2018) · European Journal of Clinical Nutrition · doi:10.1038/s41430-018-0324-6 · Cited by 59
Andrews, S., & Hamarneh, G. (2015) · IEEE Transactions on Medical Imaging · doi:10.1109/tmi.2015.2403299 · Cited by 57
Jespersen, J. G., Nedergaard, A., Reitelseder, S., Mikkelsen, U. R., Dideriksen, K., Agergaard, J., Kreiner, F. F., Pott, F. C., Schjerling, P., & Kjær, M. (2011) · PLoS ONE · doi:10.1371/journal.pone.0018090 · Cited by 57
Coleta, K. D., Silveira, L. V. D. A., Lima, D. F., Rampinelli, E. A., de Godoy, I., & Godoy, I. (2008) · Respiratory Medicine · doi:10.1016/j.rmed.2007.12.003 · Cited by 57
The clinical utility of the GOLD classification of COPD disease severity in pulmonary rehabilitation
Huijsmans, R. J., HAAN, A. D., ten Hacken, N., Straver, R. V. M., & Hul, A. J. V. ‘. (2007) · Respiratory Medicine · doi:10.1016/j.rmed.2007.07.008 · Cited by 55
Stunting is an independent predictor of mortality in patients with cystic fibrosis
Vieni, G., Faraci, S., Collura, M., Lombardo, M., Traverso, G., Cristadoro, S., Termini, L., Lucanto, M. C., Furnari, M. L., Trimarchi, G. R., et al. (2012) · Clinical Nutrition · doi:10.1016/j.clnu.2012.08.017 · Cited by 56
Kneppers, A. E. M., Langen, R. C. J., Gosker, H. R., Verdijk, L. B., Cebron Lipovec, N., Leermakers, P. A., Kelders, M. C. J. M., de Theije, C. C., Omersa, D., Lainscak, M., et al. (2017) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2017.04.016 · Cited by 55
Self-citationHighly elevated C-reactive protein levels in obese patients with COPD: A fat chance?
Breyer, M., Spruit, M. A., Celis, A. P. M., Rutten, E. P. A., Janssen, P. P., & Wouters, E. F. �. (2009) · Clinical Nutrition · doi:10.1016/j.clnu.2009.05.005 · Cited by 54
Self-citationde Blasio, F., Scalfi, L., Gregorio, A. D., Alicante, P., Bianco, A., Tantucci, C., Bellofiore, B., & Blasio, F. D. (2019) · CHEST Journal · doi:10.1016/j.chest.2019.01.001 · Cited by 54
Awano, N., Inomata, M., Kuse, N., Tone, M., Yoshimura, H., Jo, T., Takada, K., Sugimoto, C., Tanaka, T., Sumikawa, H., et al. (2019) · Respiratory Investigation · doi:10.1016/j.resinv.2019.11.002 · Cited by 54
Jouneau, S., Rousseau, C., Léderlin, M., Lescoat, A., Kerjouan, M., Chauvin, P., Paz, D. L., Guillot, S., Oger, E., Vernhet, L., et al. (2022) · Clinical Nutrition · doi:10.1016/j.clnu.2022.05.001 · Cited by 54
Aniwidyaningsih, W., Varraso, R., Cano, N., & Pison, C. (2008) · Current Opinion in Clinical Nutrition and Metabolic Care · doi:10.1097/mco.0b013e3283023d37 · Cited by 53
Budweiser, S., Meyer, K., Jörres, R. A., Heinemann, F., Wild, P. J., & Pfeifer, M. A. (2007) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1602708 · Cited by 52
Body composition and plasma levels of inflammatory biomarkers in COPD
Eagan, T., Aukrust, P., Ueland, T., Hardie, J. A., Johannessen, A., Mollnes, T. E., Damås, J. K., Bakke, P. S., & Wagner, P. D. (2010) · European Respiratory Journal · doi:10.1183/09031936.00194209 · Cited by 52
Nutrition Status and Chronic Obstructive Pulmonary Disease: Can We Move Beyond the Body Mass Index?
Raad, S., Smith, C. M., & Allen, K. S. (2019) · Nutrition in Clinical Practice · doi:10.1002/ncp.10306 · Cited by 52
Resveratrol and metabolic health in COPD: A proof-of-concept randomized controlled trial
Beijers, R. J. H. C. G., Gosker, H. R., Sanders, K. J. C., de Theije, C. C., KELDERS, M. C. J. M., Clarke, G. A., Cryan, J. F., van den Borst, B., & Schols, A. M. W. J. (2020) · Clinical Nutrition · doi:10.1016/j.clnu.2020.01.002 · Cited by 53
Self-citationThe impact of body mass index on mortality in COPD: an updated dose–response meta-analysis
Tenda, E. D., Henrina, J., Setiadharma, A., Felix, I., Yulianti, M., Pitoyo, C. W., Kho, S. S., Tay, C. K., Purnamasari, D., Soejono, C. H., et al. (2024) · European Respiratory Review · doi:10.1183/16000617.0261-2023 · Cited by 52
Mortality risk prediction in COPD by a prognostic biomarker panel
Stolz, D., Meyer, A., Rakic, J., Boeck, L., Scherr, A., & Tamm, M. (2014) · European Respiratory Journal · doi:10.1183/09031936.00043814 · Cited by 50
Obesity and Physical Activity in the Daily Life of Patients with COPD
Monteiro, F., Camillo, C. A., Vitorasso, R. L., Sant'Anna, T. J. P., Hernandes, N. A., Probst, V. S., & Pitta, F. D. O. (2012) · Lung · doi:10.1007/s00408-012-9381-0 · Cited by 55
Muscle Quality is More Impaired in Sarcopenic Patients With Chronic Obstructive Pulmonary Disease
van de Bool, C., Gosker, H. R., van den Borst, B., den Kamp, C. M. O., Slot, I. G. M., & Schols, A. M. W. J. (2016) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2015.12.094 · Cited by 50
Self-citationBody composition in patients with chronic obstructive pulmonary disease.
Gologanu, D. S., Ionita, D. L., Gartonea, T., Stanescu, C. M., & Bogdan, M. A. (2014) · PubMed Central · Cited by 50
Theeuwes, W. F., Gosker, H. R., LANGEN, R. C. J., Pansters, N., Schols, A. M. W. J., & Remels, A. H. V. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2018.06.002 · Cited by 50
Self-citationAgustí, A. G. N., & Celli, B. R. (2011) · European Respiratory Journal · doi:10.1183/09031936.00062211 · Cited by 49
Costes, F., Gosker, H., Feasson, L., Desgeorges, M., Kelders, M., Castells, J., Schols, A., & Freyssenet, D. (2015) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00557.2014 · Cited by 48
Self-citationRegulation of PGC-1α expression by a GSK-3β-TFEB signaling axis in skeletal muscle
Theeuwes, W. F., Gosker, H. R., Schols, A. M. W. J., LANGEN, R. C. J., & Remels, A. H. V. (2019) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2019.118610 · Cited by 50
Self-citationSaey, D., Lépine, P.-A., Ribeiro, F. A., Garceau-Bolduc, C., Coats, V., Maltais, F., & Allard, E. (2015) · International Journal of COPD · doi:10.2147/copd.s81806 · Cited by 47
Predicted lean body mass, fat mass and risk of lung cancer: prospective US cohort study
Jeong, S.-M., Lee, D. H., & Giovannucci, E. L. (2019) · European Journal of Epidemiology · doi:10.1007/s10654-019-00587-2 · Cited by 47
Falqueto, H., Júnior, J. L. R., Silvério, M. N. O., Farias, J. C. H., Schoenfeld, B. J., & Manfredi, L. H. (2021) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-021-09634-4 · Cited by 48
Pulmonary rehabilitation in chronic obstructive pulmonary disease
Derom, E., Marchand, É., & Troosters, T. (2007) · Annales de Réadaptation et de Médecine Physique · doi:10.1016/j.annrmp.2007.04.022 · Cited by 48
Agustí, A. G. N., Barberà, J. A., Wouters, E. F. �., Peinado, V. I., & Jeffery, P. K. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201308-1404pp · Cited by 46
Self-citationChronic obstructive pulmonary disease and malnutrition in developing countries
Sehgal, I. S., Dhooria, S., & Agarwal, R. (2016) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0000000000000356 · Cited by 46
Asakura, T., Yamada, Y., Suzuki, S., Namkoong, H., Okamori, S., Kusumoto, T., Niijima, Y., Ozaki, A., Hashimoto, M., Yagi, K., et al. (2018) · Respiratory Medicine · doi:10.1016/j.rmed.2018.10.023 · Cited by 46
How does cachexia influence survival in cancer, heart failure and other chronic diseases?
Lainscak, M., Podbregar, M., & Anker, S. D. (2007) · Current Opinion in Supportive and Palliative Care · doi:10.1097/spc.0b013e3282f31667 · Cited by 40
Bottiger, B., Nicoara, A., Snyder, L. D., Wischmeyer, P. E., Schroder, J. N., Patel, C. B., Daneshmand, M. A., Sladen, R. N., & Ghadimi, K. (2018) · Journal of Cardiothoracic and Vascular Anesthesia · doi:10.1053/j.jvca.2018.08.002 · Cited by 45
Souza, R. M. P., Cardim, A. B., Maia, T. O., da Rocha, L. G., Bezerra, S. D., & Marinho, P. É. D. M. (2019) · Physiotherapy Research International · doi:10.1002/pri.1766 · Cited by 44
Donner, C. F., ZuWallack, R., & Nici, L. L. (2021) · Medicina · doi:10.3390/medicina57070726 · Cited by 45
Longitudinal Association Between Muscle Loss and Mortality in Ever Smokers
Mason, S., Moreta-Martínez, R., Labaki, W. W., Strand, M. J., Regan, E. A., Bon, J. M., Estépar, R. S. J., Casaburi, R. H., McDonald, M., Rossiter, H. B., et al. (2021) · CHEST Journal · doi:10.1016/j.chest.2021.10.047 · Cited by 44
Ageing and COPD affect different domains of nutritional status: the ECCE study
Battaglia, S. L., Spatafora, M., Paglino, G., Pedone, C., Corsonello, A., Scichilone, N., Incalzi, R. A., & Bellia, V. (2010) · European Respiratory Journal · doi:10.1183/09031936.00032310 · Cited by 44
Esteban, C., Quintana, J. M., Moraza, J., Aburto, M., Aguirre, U., Aguirregomoscorta, J. I., Aizpiri, S., Basualdo, L. V., & Capelastegui, A. (2010) · BMC Medicine · doi:10.1186/1741-7015-8-28 · Cited by 44
Hutchinson, A. F., Brand, C. A., Irving, L. B., Roberts, C., Thompson, P. J., & Campbell, D. A. (2010) · Internal Medicine Journal · doi:10.1111/j.1445-5994.2010.02195.x · Cited by 43
Relationship between bone resorption, oxidative stress and inflammation in severe COPD exacerbation
Stanojkovic, I., Kotur‐Stevuljević, J., Spasić, S., Milenkovic, B. A., Vujić, T., Stefanović, A., & Ivanišević, J. (2013) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2013.08.003 · Cited by 43
Associations between BODE Index and Systemic Inflammatory Biomarkers in COPD
Gaki, Ε., Kontogianni, K., Papaioannou, A. Ι., Bakakos, P., Gourgoulianis, K. I., Κostikas, Κ., Alchanatis, M., Papiris, S. A., & Loukides, S. (2011) · COPD Journal of Chronic Obstructive Pulmonary Disease · doi:10.3109/15412555.2011.619599 · Cited by 42
Nutritional status of Vietnamese outpatients with chronic obstructive pulmonary disease
Hogan, D., Lan, L. T. T., Diep, D. T. N., Gallegos, D., & Collins, P. F. (2016) · Journal of Human Nutrition and Dietetics · doi:10.1111/jhn.12402 · Cited by 42
Matković, Z., Cvetko, D., Rahelić, D., Esquinas, C., Žarak, M., Miravitlles, M., & Tudorić, N. (2017) · COPD Journal of Chronic Obstructive Pulmonary Disease · doi:10.1080/15412555.2017.1386643 · Cited by 44
The pathophysiology of cachexia in chronic obstructive pulmonary disease
Schols, A. M., & Gosker, H. R. (2009) · Current Opinion in Supportive & Palliative Care · doi:10.1097/spc.0b013e328331e91c · Cited by 40
Self-citationBeijers, R. J. H. C. G., van de Bool, C., van den Borst, B., Franssen, F. M. E., Wouters, E. F. �., & Schols, A. M. W. J. (2017) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2016.12.081 · Cited by 42
Self-citationBrandt, J. D., Beijers, R. J. H. C. G., Chiles, J. W., Maddocks, M. M., McDonald, M., Schols, A. M. W. J., & Nyberg, A. (2022) · International Journal of COPD · doi:10.2147/copd.s334228 · Cited by 41
Self-citationThe Relevance of Limb Muscle Dysfunction in Chronic Obstructive Pulmonary Disease
Bui, K.-L., Nyberg, A., Rabinovich, R., Saey, D., & Maltais, F. (2019) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2019.02.013 · Cited by 41
From pre-COPD to COPD: a Simple, Low cost and easy to IMplement (SLIM) risk calculator
Divo, M. J., Liu, C., Polverino, F., Castaldi, P. J., Celli, B. R., & Tesfaigzi, Y. (2023) · European Respiratory Journal · doi:10.1183/13993003.00806-2023 · Cited by 41
The association of body mass index with mortality in the California Teachers Study
Bessonova, L., Marshall, S. F., Ziogas, A., Largent, J. A., Bernstein, L., Henderson, K. D., Ma, H., West, D. W., & Anton‐Culver, H. (2011) · International Journal of Cancer · doi:10.1002/ijc.25905 · Cited by 41
Elia, M. (2013) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2012.166 · Cited by 41
Clinical Implications of Sarcopenia on Decreased Bone Density in Men With COPD
Hwang, J. A., Kim, Y. S., Leem, A. Y., Park, M. S., Kim, S. I., Chang, J., & Jung, J. Y. (2016) · CHEST Journal · doi:10.1016/j.chest.2016.12.006 · Cited by 41
Gender differences in predictors of health status in patients with COPD
Ferrari, R., Tanni, S. É., Lucheta, P. A., Faganello, M. M., do Amaral, R. A. F., & Godoy, I. (2010) · Jornal Brasileiro de Pneumologia · doi:10.1590/s1806-37132010000100008 · Cited by 41
Gómez-Martínez, M., Rodríguez-García, W. D., González‐Islas, D., Orea‐Tejeda, A., Keirns‐Davis, C., Salgado-Fernández, F., Hernández-López, S., Jiménez‐Valentín, A., Rios-Pereda, A., Marquez-Cordero, J., et al. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12041321 · Cited by 41
Poor agreement between chart-based and objectively identified comorbidities of COPD
Triest, F. J. J., Franssen, F. M. E., Spruit, M. A., Groenen, M. T. J., Wouters, E. F. �., & Vanfleteren, L. E. G. W. (2015) · European Respiratory Journal · doi:10.1183/13993003.00667-2015 · Cited by 40
Self-citationPassey, S. L., Bozinovski, S., Vlahos, R., Anderson, G. P., & Hansen, M. J. (2016) · PLOS ONE · doi:10.1371/journal.pone.0146882 · Cited by 36
Sanders, K. J. C., Degens, J. H. R. J., Dingemans, A. C., & Schols, A. M. W. J. (2019) · International Journal of COPD · doi:10.2147/copd.s194003 · Cited by 40
Self-citationPan, L., Wang, M., Xie, X., Du, C., & Guo, Y. (2014) · PLoS ONE · doi:10.1371/journal.pone.0084855 · Cited by 40
Outcome following splenectomy in cats
Gordon, S., McClaran, J. K., Bergman, P. J., & Liu, S. M. (2010) · Journal of Feline Medicine and Surgery · doi:10.1016/j.jfms.2009.09.005 · Cited by 40
Alves, F. D., Souza, G. C., Biolo, A., & Clausell, N. (2014) · Journal of Human Nutrition and Dietetics · doi:10.1111/jhn.12218 · Cited by 40
Mineo, D., Ambrogi, V., Cufari, M. E., Gambardella, S., Pignotti, L., Pompeo, E., & Mineo, T. C. (2010) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200910-1476oc · Cited by 40
TNF-α Is Associated with Loss of Lean Body Mass Only in Already Cachectic COPD Patients
Eagan, T. M., Gabazza, E. C., D’Alessandro-Gabazza, C., Gil-Bernabe, P., Aoki, S., Hardie, J. A., Bakke, P. S., & Wagner, P. D. (2012) · Respiratory Research · doi:10.1186/1465-9921-13-48 · Cited by 39
CT Imaging and Comorbidities in COPD
Singhvi, D., & Bon, J. M. (2020) · CHEST Journal · doi:10.1016/j.chest.2020.08.2053 · Cited by 39
Nicholson, J. M., Orsso, C. E., Nourouzpour, S., Elangeswaran, B., Chohan, K., Orchanian‐Cheff, A., Fidler, L. M., Mathur, S., & Rozenberg, D. (2022) · Chronic Respiratory Disease · doi:10.1177/14799731221133387 · Cited by 39
Prevalence of osteoarthritis in individuals with COPD: a systematic review
Wshah, A., Guilcher, S. J. T., Goldstein, R. S., & Brooks, D. (2018) · International Journal of COPD · doi:10.2147/copd.s158614 · Cited by 40
Miravitlles, M., Bhutani, M., Hurst, J. R., Franssen, F. M. E., van Boven, J. F. M., Khoo, E. M., Zhang, J., Brunton, S., Stolz, D., Winders, T. A., et al. (2023) · Advances in Therapy · doi:10.1007/s12325-023-02609-8 · Cited by 38
Predictors of mortality in patients with COPD after 9 years
Prudente, R., Franco, E. A. T., Mesquita, C. B., Ferrari, R., Godoy, I., & Tanni, S. É. (2018) · International Journal of COPD · doi:10.2147/copd.s174665 · Cited by 38
Salhi, B., Huysse, W. C. J., Maele, G. V., Surmont, V. F. M., Derom, E., & van Meerbeeck, J. P. (2014) · Lung Cancer · doi:10.1016/j.lungcan.2014.01.011 · Cited by 38
Relation between physical capacity, nutritional status and systemic inflammation in COPD
Hallin, R., Janson, C., Arnardóttir, R. H., Olsson, R., Emtner, M., Branth, S., Boman, G., & Slinde, F. (2010) · The Clinical Respiratory Journal · doi:10.1111/j.1752-699x.2010.00208.x · Cited by 38
Positive Airway Pressure Titration in Obesity Hypoventilation Syndrome
Mokhlesi, B. (2007) · CHEST Journal · doi:10.1378/chest.07-0384 · Cited by 38
Risk Factors of Sarcopenia in COPD Patients: A Meta-Analysis
Zhou, J., Liu, Y., Yang, F., Jing, M., Zhong, X., Wang, Y., Liu, Y., Ming, W., Li, H., Zhao, T., et al. (2024) · International Journal of COPD · doi:10.2147/copd.s456451 · Cited by 37
Balnis, J., Korponay, T. C., Vincent, C. E., Singer, D. V., Adam, A. P., Lacomis, D., Lee, C. G., Elias, J. A., Singer, H. A., & Jaitovich, A. (2020) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00627.2019 · Cited by 36
Li, J., Lu, Y., Li, N., Li, P., Wang, Z., Ting, W., Liu, X., & Wu, W. (2020) · BioMed Research International · doi:10.1155/2020/4574509 · Cited by 37
Hopkinson, N. S., Eleftheriou, K. I., Payne, J., Nickol, A. H., Hawe, E., Moxham, J., Montgomery, H., & Polkey, M. I. (2006) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/83.4.912 · Cited by 37
Günay, E., Kaymaz, D., Selçuk, N. T., Ergün, P., Şengül, F., & Demir, N. (2013) · Respirology · doi:10.1111/resp.12133 · Cited by 37
Kelly, E. M., Owen, C. A., Pinto-Plata, V., & Celli, B. R. (2013) · Expert Review of Respiratory Medicine · doi:10.1586/ers.12.82 · Cited by 37
Farooqi, N., Slinde, F., Håglin, L., & Sandström, T. (2013) · Physiological Reports · doi:10.1002/phy2.150 · Cited by 32
Zhang, P.-F., Pan, L., Luo, Z.-Y., Zhao, H., & Cai, S. (2013) · COPD Journal of Chronic Obstructive Pulmonary Disease · doi:10.3109/15412555.2013.813928 · Cited by 37
Horadagoda, C., Dinihan, T., Roberts, M. M., & Kairaitis, K. (2017) · Internal Medicine Journal · doi:10.1111/imj.13453 · Cited by 37
Peñailillo, L., Valladares-Ide, D., Jannas-Vela, S., Flores‐Opazo, M., Jalón, M., I, L. M., Nuñez, I., & Orlando Díaz, P. (2022) · BMC Pulmonary Medicine · doi:10.1186/s12890-022-02061-4 · Cited by 36
Metadata
- Authors
- Schols, A. M., Broekhuizen, R., Weling-Scheepers, C. A., & Wouters, E. F.
- Affiliations
- Maastricht University (NL)
- Corresponding author
- Schols, Annemie MWJ
- Venue
- The American Journal of Clinical Nutrition
- Publisher
- Elsevier BV
- Published
- 2005-07
- Volume
- 82
- Issue
- 1
- Pages
- 53-59
- ISSN
- 0002-9165 (ISSN-L)
- OpenAlex
- W2150051820
- Cited by
- 902
- References
- 35
- Citations by year
- 2026: 24 · 2025: 32 · 2024: 34 · 2023: 44 · 2022: 41 · 2021: 47 · 2020: 49 · 2019: 49 · 2018: 45 · 2017: 45 · 2016: 60 · 2015: 57 · 2014: 61 · 2013: 55 · 2012: 37
- FWCI
- 19.71
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 6456 d)
- Locations
- American Journal of Clinical Nutrition (publishedVersion)
- PubMed (publishedVersion)
- Research Publications (Maastricht University) (publishedVersion, other-oa)
- Research Publications (Maastricht University) (submittedVersion, other-oa)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Chronic Obstructive Pulmonary Disease (COPD) Research
- Health Sciences › Medicine › Physiology (medical) › Nutrition and Health in Aging
- Health Sciences › Medicine › Physiology (medical) › Body Composition Measurement Techniques
- Keywords
- chronic obstructive pulmonary disease, body composition, mortality, fat-free mass index, fat mass index, skeletal muscle index, cachexia, muscle atrophy, semistarvation, disease severity
- MeSH terms
- Body Composition, Body Weight, Cachexia, Female, Humans, Male, Middle Aged, Reference Values, Respiratory Function Tests, Severity of Illness Index, Pulmonary Disease, Chronic Obstructive
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-11-19, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-11-19 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (qwen3.8-omni-flash).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.